Cassava Sciences Net Income
| SAVA Stock | USD 2.09 0.04 1.95% |
As of the 15th of February 2026, Cassava Sciences shows the Mean Deviation of 4.07, risk adjusted performance of (0.05), and Standard Deviation of 5.5. In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of Cassava Sciences, as well as the relationship between them.
Cassava Sciences Total Revenue |
|
| Last Reported | Projected for Next Year | ||
| Net Loss | -21.9 M | -23 M | |
| Net Loss | -21.9 M | -23 M | |
| Net Loss | -68.6 M | -65.2 M | |
| Net Loss | (0.47) | (0.50) | |
| Net Income Per E B T | 1.15 | 1.01 |
Cassava | Net Income | Build AI portfolio with Cassava Stock |
Analyzing Cassava Sciences's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing Cassava Sciences's current valuation and future prospects.
Latest Cassava Sciences' Net Income Growth Pattern
Below is the plot of the Net Income of Cassava Sciences over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Cassava Sciences financial statement analysis. It represents the amount of money remaining after all of Cassava Sciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Cassava Sciences' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cassava Sciences' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (24.34 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Cassava Net Income Regression Statistics
| Arithmetic Mean | (18,834,504) | |
| Geometric Mean | 13,623,898 | |
| Coefficient Of Variation | (152.14) | |
| Mean Deviation | 18,557,290 | |
| Median | (12,386,000) | |
| Standard Deviation | 28,653,942 | |
| Sample Variance | 821T | |
| Range | 128.8M | |
| R-Value | (0.57) | |
| Mean Square Error | 590.7T | |
| R-Squared | 0.33 | |
| Significance | 0.02 | |
| Slope | (3,237,477) | |
| Total Sum of Squares | 13136.8T |
Cassava Net Income History
Other Fundumenentals of Cassava Sciences
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Cassava Sciences Net Income component correlations
Cassava Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Cassava Sciences is extremely important. It helps to project a fair market value of Cassava Stock properly, considering its historical fundamentals such as Net Income. Since Cassava Sciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Cassava Sciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Cassava Sciences' interrelated accounts and indicators.
Click cells to compare fundamentals
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cassava Sciences. If investors know Cassava will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Cassava Sciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding Cassava Sciences requires distinguishing between market price and book value, where the latter reflects Cassava's accounting equity. The concept of intrinsic value - what Cassava Sciences' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Cassava Sciences' price substantially above or below its fundamental value.
Please note, there is a significant difference between Cassava Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cassava Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Cassava Sciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Cassava Sciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cassava Sciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cassava Sciences.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in Cassava Sciences on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Cassava Sciences or generate 0.0% return on investment in Cassava Sciences over 90 days. Cassava Sciences is related to or competes with Alector, PepGen, Molecular Partners, Nkarta, Cardiff Oncology, Fate Therapeutics, and Milestone Pharmaceuticals. Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases More
Cassava Sciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cassava Sciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cassava Sciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 35.02 | |||
| Value At Risk | (7.56) | |||
| Potential Upside | 9.05 |
Cassava Sciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cassava Sciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cassava Sciences' standard deviation. In reality, there are many statistical measures that can use Cassava Sciences historical prices to predict the future Cassava Sciences' volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.56) | |||
| Total Risk Alpha | (0.82) | |||
| Treynor Ratio | (0.17) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cassava Sciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cassava Sciences February 15, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (0.16) | |||
| Mean Deviation | 4.07 | |||
| Coefficient Of Variation | (1,355) | |||
| Standard Deviation | 5.5 | |||
| Variance | 30.26 | |||
| Information Ratio | (0.09) | |||
| Jensen Alpha | (0.56) | |||
| Total Risk Alpha | (0.82) | |||
| Treynor Ratio | (0.17) | |||
| Maximum Drawdown | 35.02 | |||
| Value At Risk | (7.56) | |||
| Potential Upside | 9.05 | |||
| Skewness | (0.77) | |||
| Kurtosis | 3.69 |
Cassava Sciences Backtested Returns
Cassava Sciences secures Sharpe Ratio (or Efficiency) of -0.0564, which signifies that the company had a -0.0564 % return per unit of risk over the last 3 months. Cassava Sciences exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cassava Sciences' Standard Deviation of 5.5, risk adjusted performance of (0.05), and Mean Deviation of 4.07 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 2.43, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Cassava Sciences will likely underperform. At this point, Cassava Sciences has a negative expected return of -0.31%. Please make sure to confirm Cassava Sciences' maximum drawdown, accumulation distribution, as well as the relationship between the Accumulation Distribution and day typical price , to decide if Cassava Sciences performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.17 |
Very weak predictability
Cassava Sciences has very weak predictability. Overlapping area represents the amount of predictability between Cassava Sciences time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cassava Sciences price movement. The serial correlation of 0.17 indicates that over 17.0% of current Cassava Sciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.17 | |
| Spearman Rank Test | 0.2 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Cassava Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Cassava Sciences reported net income of (24.34 Million). This is 107.13% lower than that of the Pharmaceuticals sector and 134.75% lower than that of the Health Care industry. The net income for all United States stocks is 104.26% higher than that of the company.
Cassava Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cassava Sciences' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cassava Sciences could also be used in its relative valuation, which is a method of valuing Cassava Sciences by comparing valuation metrics of similar companies.Cassava Sciences is currently under evaluation in net income category among its peers.
Cassava Sciences ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Cassava Sciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Cassava Sciences' managers, analysts, and investors.Environmental | Governance | Social |
Cassava Sciences Institutional Holders
Institutional Holdings refers to the ownership stake in Cassava Sciences that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Cassava Sciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Cassava Sciences' value.| Shares | Jane Street Group Llc | 2025-06-30 | 338.6 K | Cubist Systematic Strategies, Llc | 2025-06-30 | 309.7 K | Charles Schwab Investment Management Inc | 2025-06-30 | 265.3 K | Tang Capital Management Llc | 2025-06-30 | 239.8 K | State Street Corp | 2025-06-30 | 217.3 K | Group One Trading, Lp | 2025-06-30 | 216.4 K | Ubs Group Ag | 2025-06-30 | 190.1 K | Susquehanna Portfolio Strategies Llc | 2025-06-30 | 133.4 K | Squarepoint Ops Llc | 2025-06-30 | 106.5 K | Vanguard Group Inc | 2025-06-30 | 2.2 M | Blackrock Inc | 2025-06-30 | 1.5 M |
Cassava Fundamentals
| Return On Equity | -0.89 | ||||
| Return On Asset | -0.3 | ||||
| Current Valuation | (22.1 M) | ||||
| Shares Outstanding | 48.31 M | ||||
| Shares Owned By Insiders | 12.78 % | ||||
| Shares Owned By Institutions | 24.63 % | ||||
| Number Of Shares Shorted | 7.09 M | ||||
| Price To Book | 1.21 X | ||||
| Gross Profit | (56.99 M) | ||||
| EBITDA | (141.15 M) | ||||
| Net Income | (24.34 M) | ||||
| Cash And Equivalents | 197.23 M | ||||
| Cash Per Share | 4.92 X | ||||
| Total Debt | 11.83 M | ||||
| Current Ratio | 23.41 X | ||||
| Book Value Per Share | 3.02 X | ||||
| Cash Flow From Operations | (116.93 M) | ||||
| Short Ratio | 2.72 X | ||||
| Earnings Per Share | (2.22) X | ||||
| Price To Earnings To Growth | (0.21) X | ||||
| Target Price | 8.0 | ||||
| Number Of Employees | 30 | ||||
| Beta | -1.09 | ||||
| Market Capitalization | 142.03 M | ||||
| Total Asset | 157.53 M | ||||
| Retained Earnings | (405.11 M) | ||||
| Working Capital | 124.78 M | ||||
| Net Asset | 157.53 M |
About Cassava Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cassava Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cassava Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cassava Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Cassava Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cassava Sciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cassava Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cassava Sciences Stock:Check out For information on how to trade Cassava Stock refer to our How to Trade Cassava Stock guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cassava Sciences. If investors know Cassava will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Cassava Sciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding Cassava Sciences requires distinguishing between market price and book value, where the latter reflects Cassava's accounting equity. The concept of intrinsic value - what Cassava Sciences' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Cassava Sciences' price substantially above or below its fundamental value.
Please note, there is a significant difference between Cassava Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cassava Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Cassava Sciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.